Cytomegalovirus (CMV) immune monitoring with ELISPOT and QuantiFERON-CMV assay in seropositive kidney transplant recipients

Although cytomegalovirus (CMV) specific cell-mediated immunity (CMI) has been suggested as a predictive marker for CMV infection, proper CMI monitoring strategy in CMV-seropositive recipients and optimal method are not defined. The aim of this study was to evaluate two interferon gamma release assay...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	PloS one 2017-12, Vol.12 (12), p.e0189488-e0189488
Hauptverfasser:	Lee, Hyeyoung, Park, Ki Hyun, Ryu, Ji Hyeong, Choi, Ae-Ran, Yu, Ji Hyun, Lim, Jihyang, Han, Kyungja, Kim, Sang Il, Yang, Chul Woo, Chung, Byung Ha, Oh, Eun-Jee
Format:	Artikel
Sprache:	eng
Schlagworte:	Antigens Antiviral drugs Assaying Biology and life sciences Cell-mediated immunity Cytomegalovirus Cytomegalovirus infections Cytotoxicity Development and progression Enzyme-linked immunosorbent assay Enzymes Health aspects Immunity Infection Infections Interferon Internal medicine Kidney transplantation Kidney transplants Lymphocytes Lymphocytes T Medical laboratories Medicine Medicine and Health Sciences Monitoring Nephrology Organ transplant recipients Patients Pp65 protein Proteins Research and Analysis Methods Spots T cell receptors Transplantation Transplants & implants Viruses
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!